Chemotherapy and New Drugs in Prostate Cancer

Author:

^*Nicolas Mottet

Department of Urology, University Hospital, Hôpital Nord, St Etienne, France
*Correspondence to [email protected]

Disclosure:

N.M. has received grants or research support from Takeda/Millenium, Astellas, Pierre Fabre, Sanofi, and Pasteur; and honoraria or consultation fees from Takeda/Millenium, Jansen, Astellas, BMS, Bayer, IPSEN, Ferring, Novartis, Nuclétron, Pierre Fabre, Sanofi, and AstraZeneca.

Received:

17.12.14

Accepted:

13.02.15

Citation:

EMJ Urol. 2015;3[2]:103-110. DOI/10.33590/emjurol/10313471. https://doi.org/10.33590/emjurol/10313471.

Keywords:

Urology, EAU17.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.